Clinical trial
The Efficacy of Leflunomide for the Maintenance Therapy of ANCA Associated Vasculitis
NCT04737343 is registered in ClinicalTrials.gov with Chinese SLE Treatment And Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Leflunomide for the Maintenance Therapy of ANCA Associated Vasculitis
- Lead sponsor
- Chinese SLE Treatment And Research Group
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2021
- Completion date
- December 31, 2024
- Enrollment
- 114 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
anca associated vasculitis, maintenance therapy